Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades

Analysts at Macquarie upgraded Ball Corporation (NYSE: BLL) from Neutral to Outperform. Ball shares closed at $66.34 on Monday.

Keefe Bruyette & Woods upgraded Berkshire Hills Bancorp, Inc. (NYSE: BHLB) from Market Perform to Outperform. The price target for Berkshire Hills Bancorp has been raised from $30 to $33. Berkshire Hills Bancorp shares closed at $29.53 on Monday.

Analysts at JP Morgan upgraded TETRA Technologies, Inc. (NYSE: TTI) from Neutral to Overweight. Tetra Technologies shares closed at $7.84 on Monday.

Analysts at Goldman Sachs upgraded Marcus & Millichap Inc (NYSE: MMI) from Sell to Neutral. Marcus & Millichap shares closed at $31.22 on Monday.

Analysts at Barclays upgraded Rio Tinto plc (ADR) (NYSE: RIO) from Equal-weight to Overweight.. Rio Tinto shares closed at $34.76 on Monday.

Compass Point upgraded Credit Acceptance Corp. (NASDAQ: CACC) from Sell to Neutral. Credit Acceptance shares closed at $170.40 on Monday.

Raymond James upgraded NEWTEK Business Services Corp (NASDAQ: NEWT) from Sell to Hold. Newtek Business Services shares closed at $16.60 on Monday.

Analysts at Goldman Sachs upgraded Paramount Group Inc (NYSE: PGRE) from Hold to Buy. Paramount Group shares closed at $17.89 on Monday.

Macquarie upgraded Domtar Corp (USA) (NYSE: UFS) from Neutral to Outperform. Domtar shares closed at $41.24 on Monday.

Latest Ratings for BLL

Oct 2019MaintainsBuy
Aug 2019MaintainsOverweight
Aug 2019DowngradesOutperformMarket Perform

View More Analyst Ratings for BLL
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (BHLB + BLL)

View Comments and Join the Discussion!

Latest Ratings

ROSTMKM PartnersMaintains121.0
BJDeutsche BankMaintains27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

'No Surprises' Expected On Salesforce Earnings Call: Here's Why

Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences, Upfront Payment Of $70M Plus Additional Regulatory/Sales Milestone Payments